GalMedics

Company Overview

Snapshot

Founded in September 2008, GalMedics operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its core product, ActiLady, which is designed to treat dysmenorrhea.

Business overview

GalMedics is a biomedical company dedicated to enhancing the quality of life for menstruating women. Its primary product, ActiLady, is a device engineered to treat primary dysmenorrhea at its source. This non-invasive, over-the-counter consumer product utilizes clinically proven pressure oscillations to facilitate menstrual flow through the cervical canal, serving the health tech and life sciences sector, specifically targeting women's health within the medical devices and medical treatment & therapeutics categories.

Company Intelligence Q&A

What is GalMedics' primary product?

GalMedics' primary product is ActiLady, a device designed to treat primary dysmenorrhea by facilitating menstrual flow through pressure oscillations.

What is the current stage of development for ActiLady?

ActiLady is currently in the Clinical Trial product stage, indicating ongoing evaluation and testing.

What is GalMedics' business model?

GalMedics operates on a B2C (Business-to-Consumer) business model, aiming to directly provide its products to end-users.

When was GalMedics founded?

GalMedics was founded in September 2008, focusing on biomedical solutions for women's health.

What is the company's status?

GalMedics is currently in a Non-Active status as of October 2018.